Publicacions
-
Martínez García de la Torre RA, Vallverdú J, Xu Z, Ariño S, Ferrer-Lorente R, Zanatto L, Mercado-Gómez M, Aguilar-Bravo B, Ruiz-Blázquez P, Fernandez-Fernandez M, Navarro-Gascon A, Blasco-Roset A, Sànchez-Fernàndez-de-Landa P, Pera J, Romero-Moya D, Ayuso Garcia P, Martínez Sánchez C, Sererols Viñas L, Cantallops Vilà P, Cárcamo Giráldez CI, McQuillin A, Morgan MY, Moya-Rull D, Montserrat N, Eberlé D, Staels B, Antoine B, Azkargorta M, Lozano JJ, Martínez-Chantar ML, Giorgetti A, Elortza F, Planavila A, Varela-Rey M, Woodhoo A, Zorzano A, Graupera I, Moles A, Coll M, Affo S and Sancho-Bru P.
Trajectory analysis of hepatic stellate cell differentiation reveals metabolic regulation of cell commitment and fibrosis.
NATURE COMMUNICATIONS . 16(1): 1489-1489.
-
Peyman M, Babin-Ebell A, Rodríguez-Rodríguez R, Rigon M, Aguilar-Recarte D, Villarroya-Terrade J, Planavila A, Villarroya-Gombau F, Palomer FX, Barroso E and Vazquez M.
SIRT1 regulates hepatic vldlr levels
CELL COMMUNICATION AND SIGNALING . 22(1): 297-297. Nº de cites: 1
-
Morón S, Blasco-Roset A, Navarro-Gascon A, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Crispi F, Uriarte I, Fernández-Barrena MG, Avila M, Ferrer-Curriu G, Lupón J, Bayés-Genis A, Villarroya-Gombau F, Gavaldà-Navarro A and Planavila A.
A new FGF15/19-mediated gut-to-heart axis controls cardiac hypertrophy.
JOURNAL OF PATHOLOGY . 261(3): 335-348. Nº de cites: 3
-
Curriu GF, Rued F, López ER, García CG, Codina P, Montón CG, Roura S, Aimo A, Emdin M, Planavila A and Genís AB.
Meteorin-like protein is associated with a higher risk profile and predicts a worse outcome in patients with STEMI.
REVISTA ESPANOLA DE CARDIOLOGIA . 76(11): 891-900. Nº de cites: 6
-
Ruperez C, Blasco-Roset A, Kular D, Cairo M, Ferrer-Curriu G, Villarroya-Terrade J, MATIAS ZAMORA RODRÍGUEZ, Crispi F, Villarroya-Gombau F and Planavila A.
Autophagy is Involved in Cardiac Remodeling in Response to Environmental Temperature Change.
FRONTIERS IN PHYSIOLOGY . 13: 864427-864427. Nº de cites: 7
-
Rupérez CH, Ferrer-Curriu G, Cervera-Barea A, Florit L, Guitart-Mampel M, Garrabou G, MATIAS ZAMORA RODRÍGUEZ, Crispi F, Fernandez-Solà J, Lupón J, Bayes-Genis A, Villarroya-Gombau F and Planavila A.
Meteorin-like/Meteorin-ß protects heart against cardiac dysfunction.
JOURNAL OF EXPERIMENTAL MEDICINE . 218(5): 20201206. Nº de cites: 45
-
Ferrer-Curriu G, Guitart-Mampel M, Rupérez CH, MATIAS ZAMORA RODRÍGUEZ, Crispi F, Villarroya-Gombau F, Fernández-Solà J, Garrabou G and Planavila A.
The protective effect of fibroblast growth factor-21 in alcoholic cardiomyopathy: a role in protecting cardiac mitochondrial function.
JOURNAL OF PATHOLOGY . 253(2): 198-208. Nº de cites: 24
-
Barroso E, Rodríguez-Rodríguez R, Zarei M, Pizarro-Degado J, Planavila A, Palomer FX, Villarroya-Gombau F and Vazquez M.
SIRT3 deficiency exacerbates fatty liver by attenuating the HIF1 alpha-LIPIN 1 pathway and increasing CD36 through Nrf2
CELL COMMUNICATION AND SIGNALING . 18(1): 147-147. Nº de cites: 27
-
Palomer FX, Román-Azcona MS, Pizarro J, Planavila A, Villarroya-Gombau F, Valenzuela-Alcaraz BI, Crispi F, Sepúlveda-Martínez Á, Miguel-Escalada I, Ferrer J, Nistal JF, García R, Davidson MM, Barroso E and Vazquez M.
SIRT3-mediated inhibition of FOS through histone H3 deacetylation prevents cardiac fibrosis and inflammation.
signal transduction and targeted therapy . 5(1): 14-14. Nº de cites: 115
-
Ferrer-Curriu G, Redondo-Angulo I, Guitart-Mampel M, Ruperez C, Mas-Stachurska A, Sitges M, Garrabou G, Villarroya-Gombau F, Fernández-Solà J and Planavila A.
Fibroblast growth factor-21 protects against fibrosis in hypertensive heart disease.
JOURNAL OF PATHOLOGY . 248(1): 30-40. Nº de cites: 39